Apriglim MV 1 Tablet SR
Marketer
Aprica Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Apriglim MV 1 Tablet SR
Diabetic patients with type 2 diabetes mellitus may be prescribed the anti-diabetic medication, Apriglim MV 1 SR Tablet, a combination therapy for adults. This medication assists in regulating blood glucose. Administer this drug with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without consulting your doctor can lead to elevated blood sugar, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan that incorporates a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to manage them promptly. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks, fruit juice) are essential precautions. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headaches, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Patients with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Apriglim MV 1 Tablet SR
No information provided. Therefore, no text can be rewritten.
Uses of Apriglim MV 1 Tablet SR
Managing type 2 diabetes
Major Benefits of Apriglim MV 1 Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Apriglim MV 1 Tablet SR on an empty stomach.
Common Side effects of Apriglim MV 1 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Apriglim MV 1 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Apriglim MV 1 Tablet SR on an empty stomach.
How Apriglim MV 1 Tablet SR works:
Apriglim MV 1 sustained-release tablet contains a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Apriglim MV 1 Tablet SR and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Apriglim MV 1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Apriglim MV 1 Tablet SR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Apriglim MV 1 Tablet SR is likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is recommended. Furthermore, its use is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Exercise caution when prescribing Apriglim MV 1 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician before administration. A reduced initial dose of Apriglim MV 1 Tablet SR is typically recommended for patients exhibiting mild to moderate liver disease; its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Apriglim MV 1 Tablet SR :
Should you forget a dose of Apriglim MV 1 Tablet SR, take it immediately if you remember. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Apriglim MV 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



